Published in Am J Gastroenterol on November 01, 1997
Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis (2009) 1.10
Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment. Gut (2006) 0.91
Microscopic features of colorectal neoplasia in inflammatory bowel diseases. World J Gastroenterol (2014) 0.81
Dysplasia and colitis. Can J Gastroenterol (2009) 0.75
Influence of Visible and Near Infrared Radiant Energy on Organ Development and Pigment Synthesis in Bean and Corn. Plant Physiol (1953) 8.09
Filters for the Isolation of Narrow Regions in the Visible and Near-Visible Spectrum. Plant Physiol (1953) 7.61
Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology (1999) 5.03
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med (1995) 4.56
A Darkroom Safelight for Research in Plant Physiology. Plant Physiol (1957) 4.49
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut (2007) 4.21
Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology (1994) 3.22
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med (2000) 2.78
An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J (2001) 2.50
Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study. Aliment Pharmacol Ther (2012) 2.46
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology (2000) 2.21
Response definition criteria for ELISPOT assays revisited. Cancer Immunol Immunother (2010) 2.20
Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology (1997) 2.00
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. J Clin Oncol (1993) 1.93
Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis (1999) 1.88
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84
Isolation and characterization of Campylobacter pyloridis from gastric biopsies. Am J Clin Pathol (1987) 1.68
Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort. Aliment Pharmacol Ther (2010) 1.65
The buried gastrostomy bumper syndrome: prevention and endoscopic approaches to removal. Gastrointest Endosc (1995) 1.64
Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology (2000) 1.64
Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study. Am J Gastroenterol (2001) 1.63
Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding. Aliment Pharmacol Ther (1999) 1.60
HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse (1998) 1.58
Prevalence of Epstein-Barr Virus in a population of patients with inflammatory bowel disease: a prospective cohort study. Aliment Pharmacol Ther (2013) 1.57
Risk factors for ifosfamide nephrotoxicity in children. Lancet (1996) 1.56
A self-supporting library service in a rural region: a new look at hospital consortia. Bull Med Libr Assoc (1982) 1.54
Committee to prevent and remediate stress among house staff at the University of Alberta. CMAJ (1994) 1.54
A model of cooperation between complementary and allopathic medicine in a primary care setting. Br J Gen Pract (1990) 1.54
Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease. Aliment Pharmacol Ther (2014) 1.50
Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol (1999) 1.49
Aorto-esophageal fistula secondary to benign Barrett's ulcer: a rare cause of massive gastrointestinal hemorrhage. Can J Surg (1993) 1.48
Dysplastic tubular epithelium in "normal" kidney associated with renal cell carcinoma. Am J Surg Pathol (1994) 1.47
Unnecessary school absence after minor injury: case-control study. BMJ (2001) 1.44
Lack of correlation between Lewis antigen expression by Helicobacter pylori and gastric epithelial cells in infected patients. Gastroenterology (1998) 1.44
Colonic biopsy in verotoxin-induced hemorrhagic colitis and thrombotic thrombocytopenic purpura (TTP). Am J Clin Pathol (1986) 1.44
Familial enteropathy with villous edema and immunoglobulin G2 subclass deficiency. J Pediatr (1994) 1.44
Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators. N Engl J Med (1994) 1.43
Hot biopsy forceps in the diagnosis of endobronchial lesions. Eur Respir J (2006) 1.42
Inpatient cardiopulmonary resuscitation: is survival prediction possible? South Med J (1991) 1.41
Mixed hyperplastic adenomatous polyps--an underdiagnosed entity. Report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp. Am J Surg Pathol (1984) 1.40
Alberta Society of Gastroenterology consensus statement: Helicobacter pylori in peptic ulcer disease. Can J Gastroenterol (1997) 1.39
Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol (1998) 1.38
A controlled study of virtual reality exposure therapy for the fear of flying. J Consult Clin Psychol (2000) 1.38
Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells. Cancer Immunol Immunother (2009) 1.36
Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology (1997) 1.35
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease. Aliment Pharmacol Ther (2013) 1.32
Mutations in U1 snRNA bypass the requirement for a cell type-specific RNA splicing factor. Cell (1993) 1.27
Recognition and management of teething diarrhea among Florida pediatricians. Clin Pediatr (Phila) (1995) 1.26
Pleural multicystic mesothelial proliferation. The so-called multicystic mesothelioma. Am J Surg Pathol (1990) 1.26
A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011. Euro Surveill (2015) 1.19
Quality of life in inflammatory bowel disease. J Clin Gastroenterol (1992) 1.19
Characterization of chromosomal DNA profiles from Helicobacter pylori strains isolated from sequential gastric biopsy specimens. J Clin Microbiol (1995) 1.17
Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology (1990) 1.17
Cardiopulmonary effects of diazepam. Clin Pharmacol Ther (1973) 1.17
Aquaporin expression is downregulated in a murine model of colitis and in patients with ulcerative colitis, Crohn's disease and infectious colitis. Cell Tissue Res (2004) 1.14
Hypophosphataemic rickets after ifosfamide treatment in children. BMJ (1989) 1.13
Period and amplitude analysis of 0.5-3 c/sec activity in NREM sleep of young adults. Electroencephalogr Clin Neurophysiol (1978) 1.12
Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine (Baltimore) (1987) 1.12
Nephrotoxicity after ifosfamide. Arch Dis Child (1990) 1.10
Intrasellar solitary plasmacytoma terminating in multiple myeloma: a report of a case including electron microscopical study. Surg Neurol (1980) 1.09
Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas. Blood (1991) 1.08
Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine. Am J Physiol (1998) 1.07
Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy. Clin Cancer Res (2001) 1.07
Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am J Physiol Gastrointest Liver Physiol (2000) 1.06
Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children. Cancer Res (1993) 1.06
Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease. Can J Gastroenterol (2009) 1.06
Mucosal protective effects of vitamin E and misoprostol during acute radiation-induced enteritis in rats. Dig Dis Sci (1992) 1.05
Endogenous interleukin-10 regulates hemodynamic parameters, leukocyte-endothelial cell interactions, and microvascular permeability during endotoxemia. Circ Res (1998) 1.05
Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort. Aliment Pharmacol Ther (2010) 1.04
Transplantation antigens in Crohn's disease: Linkage of associated ankylosing spondylitis with HL-Aw27. Am J Dig Dis (1975) 1.03
Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center. Transplantation (1993) 1.03
Treatment of diabetic diarrhea with clonidine. Ann Intern Med (1985) 1.02
Mutagenesis studies of interleukin-8. Identification of a second epitope involved in receptor binding. J Biol Chem (1996) 1.01
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology (1997) 1.01
Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer (1996) 1.00
The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based study. Aliment Pharmacol Ther (2012) 1.00
Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome. J Clin Endocrinol Metab (2001) 1.00
Paracoccidioidomycosis: case report and review. Clin Infect Dis (1996) 0.99
Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group. Br J Cancer (1998) 0.99
Disseminated histoplasmosis in a nonendemic area. CMAJ (1985) 0.98
Evaluation of adjusted total thyroxine (free thyroxine index) as a measure of thyroid function. J Clin Endocrinol Metab (1972) 0.97
Acute barbiturate intoxication. Concepts of management. JAMA (1969) 0.95
Antibiotic susceptibilities of Helicobacter pylori strains isolated in the Province of Alberta. Can J Gastroenterol (1998) 0.94
The osteoclast-type giant cell tumor of the pancreas. Arch Pathol Lab Med (1987) 0.94
The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease. Can J Gastroenterol (1997) 0.94
Intestinal adaptation to diabetes. Altered Na-dependent nutrient absorption in streptozocin-treated chronically diabetic rats. J Clin Invest (1987) 0.94
FK506 increases permeability in rat intestine by inhibiting mitochondrial function. Gastroenterology (1995) 0.94
The physiology of adaptation to small bowel resection in the pig: an integrated study of morphological and functional changes. J Pediatr Surg (1990) 0.93
VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation. Can J Gastroenterol (2008) 0.93
Portal vein thrombosis after transplantation of partially purified pancreatic islets in a combined human liver/islet allograft. Transplantation (1995) 0.93
Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos (1997) 0.92
Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation (1996) 0.92
Experimental diabetic diarrhea in rats. Intestinal mucosal denervation hypersensitivity and treatment with clonidine. Gastroenterology (1986) 0.92